Delayed Reduction of Hepatitis B Viral Load and Dynamics of Adefovir-Resistant Variants during Adefovir plus Entecavir Combination Rescue Therapy

Objective: Entecavir (ETV) added to adefovir (ADV) is recommended in the consensus for management of patients with ADV resistance. However, little attention has been focused on the delayed reduction of HBV DNA and dynamics of ADV-resistant variants during ADV-ETV combination rescue therapy in the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Liu, Shuang, Chen, Yu, Zheng, Sujun, Zhou, Li, Lu, Fengmin, Duan, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441066/
https://www.ncbi.nlm.nih.gov/pubmed/26005376
http://dx.doi.org/10.7150/ijms.11687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441066/
https://www.ncbi.nlm.nih.gov/pubmed/26005376
http://dx.doi.org/10.7150/ijms.11687

Ejemplares similares